NURIX THERAPEUTICS INC
NRIXNASDAQ🏆 #1653 by market capEarnings Jan 26 · PostUS Equity
$27.26▲ $0.56 (+2.10%)
🌅 Pre-market$27.16▼ 0.37%Regular close · extended-hours price shownTrack NRIX
Get earnings, price moves & breaking news on Telegram
24h▲ 2.1%
7d—
14d—
30d—
ytd—
1y—
🏦Market Cap
$2.98B
Small Cap
📈Revenue Growth (YoY)
54.0%
High Growth
📊Gross Margin
86.5%
High
💵FCF Margin
52.7%
Strong
⚖️P/S Ratio
4.1x
Fair
Otter Score
68
Fair
NURIX THERAPEUTICS INC
NRIXAnalyst Ratings
Price
$27.26
Total
19
Raised
0
Lowered
0
Avg PT
$35.58
H / L
$45 / $31
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
HC Wainwright & Co. | Reiterated | Buy | 2026-10-16 | — | — |
RBC Capital | Reiterated | Outperform | 2026-10-13 | $35.00 | +28.40% |
Truist Securities | Reiterated | Buy | 2026-10-13 | — | — |
Oppenheimer | Reiterated | Outperform | 2026-10-13 | $32.00 | +17.40% |
Needham | Reiterated | Buy | 2026-10-13 | $34.00 | +24.70% |
Baird | Reiterated | Outperform | 2026-10-13 | — | — |
Morgan Stanley | Reiterated | Overweight | 2026-07-28 | $38.00 | +39.40% |
UBS | Reiterated | Buy | 2026-07-22 | $31.00 | +13.70% |
Mizuho | Reiterated | Outperform | 2026-07-13 | — | — |
Stifel | Reiterated | Buy | 2026-07-10 | — | — |
BTIG | Reiterated | Buy | 2026-07-10 | $32.00 | +17.40% |
Jefferies | Reiterated | Buy | 2026-06-08 | $45.00 | +65.10% |
Wells Fargo | Reiterated | Overweight | 2026-06-08 | $28.00 | +2.70% |
Piper Sandler | Reiterated | Overweight | 2026-01-29 | $32.00 | +17.40% |
Stephens & Co. | Reiterated | Overweight | 2025-07-10 | — | — |
JP Morgan | Reiterated | Overweight | 2025-01-29 | — | — |
Barclays | Reiterated | Overweight | 2024-07-15 | — | — |
SVB Leerink | Reiterated | Outperform | 2022-12-13 | — | — |
Berenberg | Reiterated | Buy | 2021-04-14 | — | — |
Institution
HC Wainwright & Co.
Reiterated · Buy · 2026-10-16
—
—
RBC Capital
Reiterated · Outperform · 2026-10-13
$35.00
+28.40%
Truist Securities
Reiterated · Buy · 2026-10-13
—
—
Oppenheimer
Reiterated · Outperform · 2026-10-13
$32.00
+17.40%
Needham
Reiterated · Buy · 2026-10-13
$34.00
+24.70%
Baird
Reiterated · Outperform · 2026-10-13
—
—
Morgan Stanley
Reiterated · Overweight · 2026-07-28
$38.00
+39.40%
UBS
Reiterated · Buy · 2026-07-22
$31.00
+13.70%
Mizuho
Reiterated · Outperform · 2026-07-13
—
—
Stifel
Reiterated · Buy · 2026-07-10
—
—
BTIG
Reiterated · Buy · 2026-07-10
$32.00
+17.40%
Jefferies
Reiterated · Buy · 2026-06-08
$45.00
+65.10%
Wells Fargo
Reiterated · Overweight · 2026-06-08
$28.00
+2.70%
Piper Sandler
Reiterated · Overweight · 2026-01-29
$32.00
+17.40%
Stephens & Co.
Reiterated · Overweight · 2025-07-10
—
—
JP Morgan
Reiterated · Overweight · 2025-01-29
—
—
Barclays
Reiterated · Overweight · 2024-07-15
—
—
SVB Leerink
Reiterated · Outperform · 2022-12-13
—
—
Berenberg
Reiterated · Buy · 2021-04-14
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space